Clinical trials
Withdrawn Phase 3 trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| AKARI Therapeutics | 1 |
| Agentschap NL | 1 |
| Celgene | 1 |
| Centocor, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Imperial College London | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| UCB Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchopulmonary Dysplasia | 1 |
| Cardiovascular Diseases | 1 |
| Crohn Disease | 1 |
| Dermatitis, Atopic | 1 |
| Eczema | 1 |
| Giant Cell Arteritis | 1 |
| Hepatitis C | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.